Literature DB >> 35768685

HCV Core protein represses DKK3 expression via epigenetic silencing and activates the Wnt/β-catenin signaling pathway during the progression of HCC.

Xiaoyan Wang1, Yun Zhou1, Chunfu Wang1, Yanyan Zhao1, Yan Cheng1, Suhuai Yu1, Xiaofeng Li1, Wenjing Zhang1, Ying Zhang1, Huiqin Quan2.   

Abstract

The Wnt/β-catenin signaling pathway is frequently activated in hepatocellular carcinoma (HCC). A number of studies have focused on the aberrant hypermethylation of the DKK family proteins and its role in regulating the activation of specific signaling pathways. However, the exact way by which DKK regulates the signaling pathway caused by Core protein of HCV has not been reported. In the present study, we evaluated the expression level of DKK and its aberrant promoter methylation to investigate the involvement of epigenetic regulation in hepatoma cell lines. The transcription and protein expression of DKK1 was significantly increased, whereas the transcription and protein expression levels of DKK2, DKK3, and DKK4 were significantly decreased following overexpression of Core protein. Pyrosequencing indicated that hypermethylation of DKK3 was increased. This was associated with increased expression of Dnmt1. The investigation of the molecular mechanism indicated that HCV Core protein interacted with Dnmt1, which combined with the promoter of DKK3, leading to methylation of DKK3. Functional studies indicated that Core protein promoted the growth, migration and invasion of cancer cells. However, upregulation of the expression of DKK3 and/or the knockdown of the expression of Dnmt1 inhibited the growth, migration and invasion of cancer cells. Taken together, the data indicated that epigenetic silencing of DKK3 caused by Dnmt1 activated the Wnt/β-catenin pathway in HCV Core-mediated HCC. Therefore, DKK3 may be a potential diagnostic and therapeutic target for HCC.
© 2022. The Author(s), under exclusive licence to Federación de Sociedades Españolas de Oncología (FESEO).

Entities:  

Keywords:  DKK3; DNA methylation; HCC; HCV Core; Wnt/β-catenin signaling

Mesh:

Substances:

Year:  2022        PMID: 35768685     DOI: 10.1007/s12094-022-02859-y

Source DB:  PubMed          Journal:  Clin Transl Oncol        ISSN: 1699-048X            Impact factor:   3.340


  51 in total

Review 1.  DNA methylation and cancer.

Authors:  Marta Kulis; Manel Esteller
Journal:  Adv Genet       Date:  2010       Impact factor: 1.944

Review 2.  Dedifferentiation of hepatocellular carcinoma: molecular mechanisms and therapeutic implications.

Authors:  Jiashuo Chao; Senlin Zhao; Hongcheng Sun
Journal:  Am J Transl Res       Date:  2020-05-15       Impact factor: 4.060

3.  Dickkopf 3 inhibits invasion and motility of Saos-2 osteosarcoma cells by modulating the Wnt-beta-catenin pathway.

Authors:  Bang H Hoang; Tadahiko Kubo; John H Healey; Rui Yang; Saminathan S Nathan; E Anders Kolb; BethAnne Mazza; Paul A Meyers; Richard Gorlick
Journal:  Cancer Res       Date:  2004-04-15       Impact factor: 12.701

4.  Promoter methylation of the Wnt/beta-catenin signaling antagonist Dkk-3 is associated with poor survival in gastric cancer.

Authors:  Jun Yu; Qian Tao; Yuen Y Cheng; Kwan Y Lee; Simon S M Ng; Kin F Cheung; Linwei Tian; Sun Y Rha; Ulf Neumann; Christoph Röcken; Matthias P A Ebert; Francis K L Chan; Joseph J Y Sung
Journal:  Cancer       Date:  2009-01-01       Impact factor: 6.860

Review 5.  DKK3 expression and function in head and neck squamous cell carcinoma and other cancers.

Authors:  Naoki Katase; Kenichi Nagano; Shuichi Fujita
Journal:  J Oral Biosci       Date:  2020-02-04

6.  MYCN is a novel oncogenic target in adult B-ALL that activates the Wnt/β-catenin pathway by suppressing DKK3.

Authors:  Desheng Kong; Linlin Zhao; Lili Sun; Shengjin Fan; Huibo Li; Yanqiu Zhao; Zhibo Guo; Leilei Lin; Lin Cui; Ke Wang; Wenjia Chen; Yihui Zhang; Jin Zhou; Yinghua Li
Journal:  J Cell Mol Med       Date:  2018-04-19       Impact factor: 5.310

7.  Long Noncoding RNA NEAT1 Suppresses Proliferation and Promotes Apoptosis of Glioma Cells Via Downregulating MiR-92b.

Authors:  Dongdong Liu; Zheng Zou; Gen Li; Pengyu Pan; Guobiao Liang
Journal:  Cancer Control       Date:  2020 Jan-Dec       Impact factor: 3.302

Review 8.  Epigenetics in liver disease: from biology to therapeutics.

Authors:  Timothy Hardy; Derek A Mann
Journal:  Gut       Date:  2016-09-13       Impact factor: 23.059

9.  Dickkopf-3 Causes Neuroprotection by Inducing Vascular Endothelial Growth Factor.

Authors:  Carla Letizia Busceti; Luisa Di Menna; Franca Bianchi; Federica Mastroiacovo; Paola Di Pietro; Anna Traficante; Giovanna Bozza; Christof Niehrs; Giuseppe Battaglia; Valeria Bruno; Francesco Fornai; Massimo Volpe; Speranza Rubattu; Ferdinando Nicoletti
Journal:  Front Cell Neurosci       Date:  2018-09-11       Impact factor: 5.505

10.  Clinical features of hepatocellular carcinoma with hepatitis B virus among patients on Nucleos(t) ide analog therapy.

Authors:  Li Liu
Journal:  Infect Agent Cancer       Date:  2020-02-04       Impact factor: 2.965

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.